Citius Pharmaceuticals, Inc. Fair Value Adjustment of Warrants
Citius Pharmaceuticals, Inc. (CTXR) had Fair Value Adjustment of Warrants of $11.00 million as of 2023-05-08, per its 10-K filed 2023-12-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-12-29
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2021-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2016-06-30 was $494.56K, a 17.73% increase year-over-year.
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for the quarter ending 2016-03-31 was $546.02K.
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2021 was $1.45M.
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2016 was $1.20M, a 55.97% increase from fiscal 2015.
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2015 was $768.43K, a 47.35% decline from fiscal 2014.
- Citius Pharmaceuticals, Inc. fair value adjustment of warrants for fiscal 2014 was $1.46M.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2023-05-08 | $11.00M 10-K · filed 2023-12-29 | ||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $1.45M 10-K · filed 2021-12-15 | |||
| 2021-06-30 | $1.45M 10-Q · filed 2021-08-12 | ||||
| 2017-06-30 | $641.38K 10-Q · filed 2017-08-14 | ||||
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $494.56K derived: sum of 2 quarters · filed 2017-08-14 | $1.04M derived: sum of 3 quarters · filed 2017-08-14 | $1.20M 10-K · filed 2016-12-23 | |
| 2016-06-30 | $494.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | $1.04M derived: sum of 2 quarters · filed 2017-08-14 | $1.20M 10-Q · filed 2017-08-14 | $1.43M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $546.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $704.00K 10-Q · filed 2017-05-15 | $934.39K derived: sum of 3 quarters · filed 2017-05-15 | $1.35M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $157.98K 10-Q · filed 2017-02-14 | $388.37K derived: sum of 2 quarters · filed 2017-02-14 | $808.44K derived: sum of 3 quarters · filed 2017-02-14 | ||
| 2015-09-30 | $230.38K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $650.46K derived: sum of 2 quarters · filed 2016-12-23 | $768.43K 10-K · filed 2016-12-23 | ||
| 2015-06-30 | $420.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $538.05K 10-Q · filed 2016-08-15 | |||
| 2015-03-31 | $117.98K 10-Q · filed 2016-05-20 | ||||
| 2014-09-30 | $1.46M 10-K · filed 2015-12-14 | $1.46M 10-K · filed 2016-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |